Discontinued — last reported Q3 '24

Other

Shares Repurchased

Vertex Pharmaceuticals Shares Repurchased remained flat by 0.0% to 1.2M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 77.8%, from 675K to 1.2M. Over 2 years (FY 2023 to FY 2025), Shares Repurchased shows an upward trend with a 92.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalHigher is better
VolatilityVolatile
First reportedQ1 2023
Last reportedQ3 2024

How to read this metric

Higher repurchases often signal management's confidence in the company's valuation and a commitment to returning capital to shareholders.

Detailed definition

This is the total number of common shares bought back by the company from the open market during the period. It is a pri...

Peer comparison

A standard metric for evaluating capital return strategies across all sectors.

Metric ID: is_cvx_shares_repurchased

Historical Data

3 years
 FY'23FY'24FY'25
Value1.3M2.7M4.8M
YoY Change—+107.7%+77.8%
Range1.3M – 4.8M
CAGR+92.2%
Avg YoY Growth+92.7%
Median YoY Growth+92.7%
Current Streak2+ years growth

Frequently Asked Questions

What is Vertex Pharmaceuticals's shares repurchased?
Vertex Pharmaceuticals (VRTX) reported shares repurchased of 1.2M in Q4 2025.
How has Vertex Pharmaceuticals's shares repurchased changed year-over-year?
Vertex Pharmaceuticals's shares repurchased increased by 77.8% year-over-year, from 675K to 1.2M.
What is the long-term trend for Vertex Pharmaceuticals's shares repurchased?
Over 2 years (2023 to 2025), Vertex Pharmaceuticals's shares repurchased has grown at a 92.2% compound annual growth rate (CAGR), from 1.3M to 4.8M.
What does shares repurchased mean?
The total count of shares bought back by the company.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.